On February 6, 2024, Dr. Seibler delivered his inaugural lecture entitled “Zellen im Wandel: Personalisierte Zellmodelle für neurologische Erkrankungen durch Reprogrammierung.”
In his lecture, Dr. Seibler presented key aspects of his research approach, with a focus on the reprogramming of patients’ somatic cells into induced pluripotent stem cells (iPSCs). He further highlighted how these cells can be differentiated into neurons and glial cells to create personalized cellular models of neurological diseases.
This work provides an important foundation for studying disease mechanisms in a patient-specific context and opens new perspectives for translational research in neurology. By combining innovative cellular models with clinically relevant questions, Dr. Seibler’s research contributes to a deeper understanding of neurological disorders and to the development of more targeted therapeutic strategies.
ProtectMove warmly congratulates Dr. Seibler on this important academic milestone and wishes him continued success in his research.